Russia Develops mRNA Cancer Vaccine
Russia has developed a new mRNA cancer vaccine, demonstrating potential in pre-clinical trials to suppress tumor growth and prevent cancer spread. This vaccine, supported by artificial intelligence (AI), simplifies the design process for personalized treatments, significantly reducing time. It will be offered free of charge starting in 2025. There are two types of cancer vaccines: therapeutic, targeting existing cancer cells, and preventive, like the HPV vaccine. The Russian mRNA vaccine is a therapeutic one, enhancing immune response against cancer markers. This breakthrough underscores the role of innovation in healthcare, promising advancements in cancer treatment worldwide.
If you like this post, please share your feedback in the comments section below so that we will upload more posts like this.
